baber/WOPTO huggingface dataset:
Patent DK-1542560-T3 (DK)
Inventor: OHLE INGO
IPC: A44B13/00
Filed: 2003-09-17
Granted: 2008-10-13
Abstract: A slightly elastic plastic shell designed in a drop shape with a flanged circular central opening (6) and a flanged outer contour (31) is clipped to a similar shell (4) additionally equipped with small pointed projections (17) after the unit (3) has been attached to both sides of a hole (2) located at a textile item (1). A rotation of one shell (4) around the other can be avoided by the specific shape (32).
Patent DK-1624936-T3 (DK)
Inventor: DE KONINCK YVES
IPC: G01N33/50
Filed: 2004-05-14
Granted: 2010-03-15
Abstract: Methods and products for the attenuation or treatment of pain and the reduction of nociception are described. The methods and products are based on the modulation of CNS intracellular chloride levels. The methods and products may also relate to modulation of the activity and/or expression of a chloride transporter, such as the KCC2 potassium-chloride cotransporter. Also described herein are commercial packages and uses based on such modulation. Related methods for identifying or characterizing a compound for the treatment of pain, the reduction of nociception and the diagnosis and prognostication of pain are also described.
Patent DK-1559438-T3 (DK)
Inventor: PENDHARKAR SANYOG M
IPC: A61P7/04
Filed: 2005-01-31
Granted: 2011-02-21
Abstract: The present invention includes both sterilized and unsterilized hemostatic compositions that contain a biocompatible liquid having particles of a biocompatible polymer suitable for use in hemostasis and which is substantially insoluble in the liquid, up to about 20 percent by weight of glycerol and about 1 percent by weight of benzalkonium chloride, each based on the weight of the liquid, all of which are substantially homogenously dispersed throughout the liquid to form a substantially homogenous composition, methods for making such compositions, medical devices that contain such hemostatic compositions disposed therein and methods of making such devices.
Patent DK-1725671-T3 (DK)
Inventor: HUGHES JONATHAN
IPC: C12P13/00
Filed: 2005-03-09
Granted: 2010-04-12
Abstract: A biocatalytic method for the synthesis of 2-(N,N-dimethyl amino)ethanol and/or choline esters of acrylic acid and/or methacrylic acid comprising reacting 2-(N,N-dimethylamino)ethanol and/or choline with acrylyl-CoA and/or methacrylyl-coA in the presence of a biocatalyst with choline acetyltransferase activity. The acrylyl-CoA and/or the methacrylyl CoA is formed by the reaction of acrylate and/or methacrylate with coenzyme A in the presence of ATP and a biocatalyst with S-acetyl coenzyme A synthetase activity.
Patent DK-1792417-T3 (DK)
Inventor: KASTURI NITIN
IPC: H04W52/22
Filed: 2005-09-08
Granted: 2012-06-25
Abstract: An apparatus, system, and method efficiently manage transmission power in a user equipment (UE) device by maintaining and applying an authorized power level to determine a transmission power level after a power limited transmission and before a new power control command has been received. The UE device maintains the authorized power level by monitoring and adjusting the authorized power level based on received power control commands. After a power limited transmission where the maximum power level is less than the authorized power level, the UE device determines the transmission power level for the next transmission based on the authorized power level. Accordingly, after the power limiting situation has ceased, the UE device transmits at the optimum power level eliminating the inefficiencies of transmitting at a lower than authorized power before the next power control command is received.
Patent DK-1785154-T3 (DK)
Inventor: CAPEL ANTOINE
IPC: A61L33/00
Filed: 2006-10-25
Granted: 2009-11-23
Abstract: The hemocompatible material has a strong and tight synthetic substrate to which a biological animal tissue such as animal e.g. bovine, pericardium, is adhered by dispersing a substrate constituting material in a solvent. The substrate is made of elastomer such as polyurethane or silicone elastomer. The tissue is treated for several days using a glycol such as polyethyleneglycol, once adhered on the substrate. An independent claim is also included for a method for fabricating a hemocompatible material.
Patent DK-1906928-T3 (DK)
Inventor: GUSTAFSSON NILS OVE
IPC: A61K9/16
Filed: 2006-05-24
Granted: 2009-04-20
Abstract: The present invention relates to novel processes for the manufacture of cores of a specific polymer and a biologically active substance, and of such cores carrying a shell, i.e. microcapsules, to the cores and microcapsules thus produced, and to a pharmaceutical composition comprising such microcapsules.
Patent DK-1897558-T3 (DK)
Inventor: SUZUKI H
IPC: A61P9/10
Filed: 2006-06-09
Granted: 2013-12-09
Abstract: The solid preparation of the present invention aims at providing a solid preparation superior in the stability during production and preservation even when a poorly water-soluble substance having a low melting point is contained in a large amount, and also superior in the disintegration property and release property of a poorly water-soluble substance having a low melting point, after oral administration, and is  characterized by  the following 1) to 3): 1) containing a poorly water-soluble substance having a low melting point, a saccharide, and a cellulose selected from a crystalline cellulose and a low-substituted hydroxypropylcellulose, 2) a saccharide/cellulose weight ratio exceeding 2, and 3) a cellulose content of not less than 5 wt%.
Patent DK-1910436-T3 (DK)
Inventor: KOCH KLAUS-UWE
IPC: C08G18/67
Filed: 2006-07-14
Granted: 2009-05-25
Abstract: Disclosed are anhydrous transparent dispersions of polyurethane(meth)acrylate particles in a reactive diluent, which can be obtained by reacting a polyisocyanate with at least one polyol and a nucleophilically functionalized (meth)acrylic acid ester in the reactive diluent. The inventive dispersions are characterized in that the polyurethane(meth)acrylate particles have an average diamert of less than 40 nm. The invention further relates to a method for producing such dispersions, the use thereof as an adhesive, cut glass, or impact resistance modifier, and a molded article made from said dispersion.
Patent DK-1937221-T3 (DK)
Inventor: SOENNICHSEN CAREN
IPC: A61K9/20
Filed: 2006-09-29
Granted: 2009-06-15
Abstract: This invention relates to a sustained release tablet comprising at least two layers, wherein at least one layer rapidly releases pralnacasan and the other layer releases pralnacasan in a delayed manner. This tablet is particularly suitable for the treatment of a condition such as autoimmune diseases, type I and type II diabetes, rheumatoid arthritis, osteoarthritis or psoriasis.
Patent DK-1945405-T3 (DK)
Inventor: FREYERMUTH ALAIN
IPC: B23Q16/00
Filed: 2006-09-12
Granted: 2010-03-22
Abstract: The invention concerns a method and device for adjusting the fitting depth of a tool in a tool-holder, in particular in a tool-holder to be banded. The method is characterized in that it consists in performing a prior calibration of a sensing assembly (2) by positioning a sensing slide (4) of said assembly (2) into a bore (V) of a calibrating support (1) and by re-setting a viewing means of said sensing assembly (2), then in positioning the sensing assembly above a tool-holder and moving the adjustable stop of said tool-holder towards the sensing slide (4), so as to determine a travel thereof corresponding to the required fitting depth. The invention is applicable in the field of the environment of machine-tools, more particularly comprising tool-holders to be banded.
Patent DK-1780969-T3 (DK)
Inventor: TZANNES MARCOS C
IPC: H04J11/00
Filed: 2001-06-08
Granted: 2010-07-12
Abstract: A multi-carrier modulation transceiver and a method for multi-carrier modulation communication are proposed. One or more tones are disabled during initialization based on a received tone-disable message. A multi-carrier receiver can determine the message that specifies one or more tones that are to be disabled during initialization.
Patent DK-1818356-T3 (DK)
Inventor: KRAEMER HANS-GEORG
IPC: C08J3/18
Filed: 2007-02-02
Granted: 2008-09-15
Abstract: The use of triglycerides (I) as plasticizers for polyolefins. An independent claim is included for a method for the production of plasticized or softened objects containing polyolefins by mixing the granulated polymer with 0.1-40 wt% (I) and then processing to fibres or film by known methods.
Patent DK-2072075-T3 (DK)
Inventor: KULL OESTERLIN KRISTINA
IPC: A61F5/44
Filed: 2007-12-21
Granted: 2010-11-15
Abstract: There is disclosed a catheter assembly (1) comprising a catheter (2) and a receptacle (3). The receptacle has an elongate pocket (4), for accommodating at least an insertable end of said catheter, a urine collection bag (5), having a width extension (W bag ) wider than a greatest width of said elongate pocket, and at least two tab areas on at least one tab (6) are arranged at the periphery of the urine collection bag on opposite sides of said bag. Further, in a storage state, said elongate pocket is folded over said urine collection bag, and lateral parts of said urine collection bag extending outside said elongate pocket are folded towards each other over said elongate pocket, said lateral parts being dimensioned to overlap each other in the folded disposition, and wherein said tab areas are arranged on said lateral parts and are attached to each other, in at least one point of attachment, to releasably maintain said catheter assembly in a folded disposition during storage.
Patent DK-2041199-T3 (DK)
Inventor: ANDRIES KRIS
IPC: C08G18/36
Filed: 2007-06-12
Granted: 2010-03-29
Abstract: Process for making a slabstock, visco-elastic, flexible, polyurethane foam which process comprises reacting a polyisocyanate and a polyol at an index of 60-95 and using a blowing agent, wherein 5-50 and preferably 10-40% by weight of the polyol used is castor oil. The foams and a polyol composition are claimed as well.
Patent DK-2099588-T3 (DK)
Inventor: NAJDOVSKI ZORAN
IPC: B25J13/00
Filed: 2007-12-19
Granted: 2012-02-06
Abstract: The present invention provides remote interfacing utilising haptic technology. In a first aspect there is provided a haptic grasping interface comprising a plurality of finger interaction points, with actuators connected at one end to an actuator control mechanism. The mechanism is mounted remotely from the grasping interface, inverse to the finger interaction points, for manipulation of these points. The grasping points comprise pulleys which route the actuators through a cable tension and transmission system. A second aspect provides haptic augmentation to an operator, which indicates to the operator the state of a control input to a controlled device. A third aspect provides a means of simulating motion where haptic feedback is provided to a user in correspondence with the movement of the user within a pod environment.
Patent DK-1969971-T3 (DK)
Inventor: BELL JAMES
IPC: A47C21/02
Filed: 2008-02-28
Granted: 2010-07-26
Abstract: A mattress encasement made of bug impervious fabric provides a zipper opening for removal of the mattress. A foam pad is stitched at an end of the zipper closure such that when the zipper is located at or near the end, a channel is provided to prevent or obstruct the escapement of bed bugs via the channel and out from a mattress encased by the mattress encasement.
Patent DK-2223493-T3 (DK)
Inventor: FORSBERG DAN LARS ANDERS
IPC: H04W12/06
Filed: 2008-12-08
Granted: 2018-01-29
Abstract: It is disclosed a method comprising receiving, prior to a handover operation, first key indication information, creating, prior to the handover operation, key information based on the received first key indication information, retaining the created key information, sending, after the handover operation, the received first key indication information associated with the key information created prior to the handover operation, and retrieving, after the handover operation, the retained key information based on the first key indication information; and a method comprising generating, prior to the handover operation, the first key indication information associated with key information intended to be created, sending, prior to the handover operation, the generated first key indication information, and receiving, after the handover operation, second key indication information corresponding to the generated first key indication information.
Patent DK-2251428-T3 (DK)
Inventor: KOS HENRY
IPC: A23G1/00
Filed: 2009-05-11
Granted: 2012-01-30
Abstract: A process for preparing a triglyceride composition comprising from 50 to 80 % by weight StOSt and from 5 to 20 % by weight StOO comprises reacting triolein with stearic acid in the presence of a 1,3- specific lipase from  Rhizopus oryzae  to form interesterified glycerides and fractionating the interesterified triglycerides.
Patent DK-2345451-T3 (DK)
Inventor: PALTI YORAM
IPC: A61N1/40
Filed: 2005-12-05
Granted: 2018-04-23
Abstract: An electrode configured for placement in contact with a surface of a patient's body, the electrode comprising: a flexible support; and a plurality of parallel electrode elements (45; 55, 55') which are supported by the flexible support to permit the electrode to conform to the surface of the patient's body and separated by open spaces (48; 58), wherein the electrode elements (45; 55, 55') are made of conductive wire (43) surrounded by a dielectric coating (42) to insulate the conductive wire (43) from the patient's body when the electrode is placed in contact with the patient's body, wherein the open spaces (48; 58) are distributed and sized to permit moisture on the surface of the patient's body to escape via the open spaces (48; 58) when the electrode is placed in contact with the patient's body.
Patent DK-2322929-T3 (DK)
Inventor: BAMDAD CYNTHIA
IPC: G01N33/68
Filed: 2001-11-27
Granted: 2016-07-25
Abstract: The invention provides a series of compositions, methods, kits, articles and species associated primarily with the diagnosis and/or treatment of cell proliferation, specifically cancer. Cell proliferation associated with aberrant expression of MUCI is particularly focused upon. Mechanisms associated with MUCI cell proliferation are discussed.
Patent DK-2264050-T3 (DK)
Inventor: HALBUR PATRICK G
IPC: C12N15/34
Filed: 2002-12-11
Granted: 2018-12-03
Abstract: The present invention relates to an immunogenic polypeptide product which is obtainable by expressing infectious chimeric DNA clones of porcine circovirus (PCV). The present invention also relates to corresponding vaccines and means of protecting pigs against viral infection or postweaning multisystemic wasting syndrome (PMWS) caused by PCV2. The new chimeric infectious DNA clone is constructed from the nonpathogenic PCV1 in which the immunogenic ORF gene of the pathogenic PCV2 replaces a gene of the nonpathogenic PCV1, preferably in the same position.
Patent DK-2608806-T3 (DK)
Inventor: RUISS ROMANA
IPC: C12N7/04
Filed: 2011-08-25
Granted: 2018-01-29
Abstract: The present invention relates to a vaccine comprising a particle, said particle comprising (i) at least one Epstein-Barr virus (EBV) structural polypeptide, (ii) at least one EBV lytic polypeptide, (iii) membrane lipids, said particle being devoid of EBV DNA, wherein (a) the B-cell transformation capacity of one or more EBV polypeptides required for B-cell transformation as comprised in said particle is disabled while their immunogenicity is maintained; and or (b) said particle is devoid of one or more EBV polypeptides required for B-cell transformation. Furthermore, the invention relates to a method for generating a particle, to a cell obtained in the method of the invention, a kit comprising the vaccine or the particle generated according in the method of the invention. Also, the invention relates to the use of the vaccine or the particle generated according to the method of the invention for generating CD8+ cells specific for an EBV antigen.
Patent DK-2683590-T3 (DK)
Inventor: EBERLEIN MARTIN
IPC: B62B3/14
Filed: 2012-03-06
Granted: 2018-02-26
Abstract: The invention relates to a shopping trolley (1) which is stackable with similar trolleys, comprising a chassis (2), a container (18) for holding goods which is connected to the chassis (2), and a pushing device (20) disposed at the rear, wherein the chassis (2) has two curved longitudinal supports (3) leading from the rear face to the front face of the shopping trolley (1). A fastening means (11) for fastening a castor (16, 17) is provided at each end on the front and rear end sections of the longitudinal supports (4, 4') which are connected to one another by respective intermediate portions (4"). Furthermore the longitudinal supports (3) are disposed conically such that the track width of the rear castors (17) is greater than the track width of the front castors (16), the two longitudinal supports (3) extend upwards and forwards from the rear end section (4') thereof and then, falling forwards towards the front end section (4), extend further such that at least the intermediate section (4") of each longitudinal support (3) belongs to one of two geometrical planes (25) which extend upwards from the plane of travel (26) of the castors (16, 17). The invention is characterised in that the front end sections (4) are led out of the planes (25) and extend either forwards and parallel to the direction of pushing of the shopping trolley (1) or in opposite directions obliquely forwards and outwards or are directed outwards transversely with respect to the direction of pushing of the shopping trolley (1).
Patent DK-2714031-T3 (DK)
Inventor: AGARWAL VEENA
IPC: A61P35/00
Filed: 2012-05-30
Granted: 2018-08-06
Abstract: The present invention relates to a pharmaceutical combination for use in the treatment of squamous cell carcinoma, comprising a CDK inhibitor selected from the compounds of formula (I); or a pharmaceutically acceptable salt thereof and one or more antineoplastic agents selected from sorafenib, lapatinib, erlotinib, cisplatin, 5-fluorouracil, docetaxel or cetuximab or a pharmaceutically acceptable salt thereof. The said pharmaceutical combination exhibits synergy when used in the treatment of squamous cell carcinoma of head and neck (SCCHN). The invention also relates to a pharmaceutical composition comprising the said combination and a method for the treatment of squamous cell carcinoma of head and neck (SCCHN), using a therapeutically effective amount of said combination.
Patent DK-2791675-T3 (DK)
Inventor: WEBER ALFRED
IPC: G01N33/564
Filed: 2012-12-13
Granted: 2018-07-30
Abstract: Methods for detecting or capturing low-avidity autoantibodies in a biological sample are provided. Target antigen used to assay for the low-avidity autoantibodies of interest is immobilized on a solid phase. The biological sample is contacted under low conductivity condition with the target antigen for which the autoantibodies has specific binding affinity. Binding of the target antigen to the autoantibodies of interest in the biological sample is then detected to ascertain the presence or concentration of the autoantibodies of interest.
Patent DK-0394899-T3 (DK)
Inventor: GROS JEAN-PIERRE
IPC: F02C7/20
Filed: 1990-04-23
Granted: 1993-06-14
Abstract: The system comprises a wall (21) integral with a concrete raft (5) equipped with a circular orifice (22), through which the outlet (1) passes, and ties or arms (12) pass through the wall of the outlet and are fastened to the wall in order to support the bearing (7) on the outlet side. 
<??>An increase in the rigidity of the bearing (7) supporting the rotor makes it possible to ensure a higher stability of the bearing towards major accidents, for example, the loss of a last blade (BP). 
<??>Furthermore, as a result of the separation of the bearing function from the outlet bottom function of the stator, any unbalance of the rotor cannot excite a natural mode of the structure of the stator. 
<IMAGE>
Patent DK-0426973-T3 (DK)
Inventor: CHIU CHUNG-WAI DR
IPC: C12P7/06
Filed: 1990-09-10
Granted: 1994-12-12
Abstract: Dilute molasses solutions are generally acidified with the aid of sulphuric acid and then employed as nutrient medium for fermentations. However, used nutrient solutions lead on anaerobic methanisation, because of the sulphate content, to biogas containing hydrogen sulphide. It is now possible to acidify molasses solutions to an adequate extent with the aid of ion exchangers. These molasses solutions are comparable with customary molasses solutions in fermentations, and they produce an improved biogas in the methanisation. Preparation of acidified molasses solutions and their use in fermentation processes.
Patent DK-0438684-T3 (DK)
Inventor: NILSSON RICHARD CORY
IPC: G02B6/44
Filed: 1990-12-07
Granted: 1999-06-07
Abstract: The optical fiber cable has a plurality of centrally located optical fibers. Carrying the optical fibers is a gel-filled plastic buffer tube. A plurality of radial strength yarn threads extend along the outside of the buffer tube in a contra-helical pattern. In the armored cable embodiment, a strength and protective member in the form of a corrugated steel armor layer may be provided for additional protection against possible rodent damage. The armor is usually coated with a thin layer of plastic material in the form of a water blockable flooding compound. A ripcord is provided to assist in removal of the armor. A final polyethylene outer jacket is provided for additional cable protection. Embedded within the outer jacket is a pair of diametrically opposed, longitudinally extending strength members. <IMAGE>
Patent DK-0409506-T3 (DK)
Inventor: MCDONALD KEVIN
IPC: E03C1/122
Filed: 1990-07-13
Granted: 1992-11-23
Abstract: A valve device 1 for admitting air to a pipe such as a stack pipe 2 in a domestic toilet system is shown. The valve device 1 comprises a body 3 adapted to be mounted on the pipe 2 at an open end 4 of the body 3 which has a closed end provided by an end closure or a cap 5 with a depending skirt 6 which reaches to the lower (as viewed) limit of an opening 7 in the body 3 to atmospheric air. The body 3 has an internal wall 8 which extends part way across the body 3 internally, the internal wall 8 having a through orifice or hole 9 and being part cylindrical. An upwardly extending part 10 of the wall 8 and a part 11 terminate in a nose 12 which supports the underside of a valve member 13.
Patent DK-0419280-T3 (DK)
Inventor: ALLEN THOMAS E
IPC: B01F13/10
Filed: 1990-09-21
Granted: 1995-02-27
Abstract: A mixing apparatus (102) especially suitable for mixing dry cement with water, comprises a tub (106) having a larger cross-sectional area at its top than at the bottom, a flow mixer (104) in the tub for mixing a dry substance with a liquid in a downwardly spiralling flow and having at least two recirculation inlets, an agitator (108) disposed obliquely in the tub to circulate the mixture in the tub, and recirculation means (110) connected between the tub and the recirculation inlets to recirculate the mixture.
Patent DK-0388261-T3 (DK)
Inventor: MINIER CHANTAL
IPC: A23L11/00
Filed: 1990-03-09
Granted: 1993-06-07
Abstract: Method for treating beans which consists in treating them with steam, then in soaking them in water, then in pre-cooking them and in sterilising them.
Patent DK-0395526-T3 (DK)
Inventor: LESIEUR DANIEL
IPC: A61P25/04
Filed: 1990-04-27
Granted: 1994-06-27
Abstract: Compounds of general formula (I):   <IMAGE> (I)  in which: R1 represents a hydrogen atom or a lower alkyl group, R2 represents a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted thienyl, furyl, pyrrolyl or pyridinyl group, X represents a hydrogen atom, Y represents a hydroxyl group, or else X and Y together represent an oxygen atom, their enantiomers, diastereoisomers and epimers. Medicaments.